Prostaglandin E2 stimulates amyloid precursor protein gene expression: Inhibition by immunosuppressants

Journal of Neuroscience

Volumn 19, Issue 3, 1999, Pages 940-947

  Lee, Robert K K ^a,b   Knapp, Stefan ^a   Wurtman, Richard J ^a  

^a HARVARD UNIVERSITY   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Astrocytes; cAMP; Cyclosporin A; FK506; Inflammation; Rapamycin

Indexed keywords

8 BROMO CYCLIC AMP; AMYLOID PRECURSOR PROTEIN; CYCLOHEXIMIDE; CYCLOSPORIN A; DACTINOMYCIN; FORSKOLIN; GLIAL FIBRILLARY ACIDIC PROTEIN; OKADAIC ACID; PROSTAGLANDIN E2; PROTEIN; RAPAMYCIN; TACROLIMUS; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; MESSENGER RNA;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BRAIN INJURY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TRANSGENIC MOUSE; WESTERN BLOTTING; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; GENE EXPRESSION; GENETICS; METABOLISM; PHYSIOLOGY; RAT;

AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYCLOSPORINE; DINOPROSTONE; DRUG SYNERGISM; GENE EXPRESSION; GENE EXPRESSION REGULATION; IMMUNOSUPPRESSIVE AGENTS; RATS; RNA, MESSENGER; TACROLIMUS;

EID: 0033068185     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.19-03-00940.1999     Document Type: Article

References (42)

1. Alzheimer A (1907) Über eine eigenartige Erkrankung der Hirnrinde. Allg Z Psychiatr Psychol-Gerichtl Med 64:146-148.
2. Banati RB, Gehrmann J, Wießner C, Hossman K-A, Kreutzberg GW (1995) Glial expression of the β-amyloid precursor protein (APP) in global ischemia. J Cereb Blood Flow Metab 12:257-269.
3. Bourbonniére M, Shekarabi M, Nalbantoglu J (1997) Enhanced expression of amyloid precursor protein in response to dibutyryl cyclic AMP is not mediated by the transcription factor AP-2. J Neurochem 68:909-916.
4. Brun A, Liu X, Erikson C (1995) Synapse loss and gliosis in the molecular layer of cerebral cortex in Alzheimer's disease and in frontal lobe degeneration. Neurodegeneration 4:171-177.
5. 2 after transient global forebrain ischemia in the rat. Stroke 27:527-535.
6. Cordell B (1994) β-amyloid formation as a potential therapeutic target for Alzheimer's disease. Annu Rev Pharmacol Toxicol 34:69-89.
7. Efthimiopoulos S, Vassilacopoulou D, Ripellino JA, Tezapsidis N, Robakis N (1996) Cholinergic agonists stimulate secretion of soluble full-length amyloid precursor protein in neuroendocrine cells. Proc Natl Acad Sci USA 93:8046-8050.
8. Esch FS, Keim PS, Beattie EC, Blacher RW, Culwell AR, Oltersdorf T, McClure D, Ward PJ (1990) Cleavage of amyloid β peptide during constitutive processing of its precursor. Science 248:1122-1124.
9. Goetzl EJ, An S, Smith WL (1995) Specificity of expression and effects of eicosanoid mediators in normal physiology and human diseases. FASEB J 9:1051-1058.
10. Golde TE, Estus S, Usiak M, Younkin LH, Younkin SG (1990) Expression of β amyloid protein precursor mRNAs: recognition of a novel alternatively spliced form and quantitation in Alzheimer's disease using PCR. Neuron 4:253-267.
11. Heinonen O, Soininen H, Sorvari H, Kosunen O, Paljärvi L, Koivisto E, Riekkinen PJ (1995) Loss of synaptophysin-like immunoreactivity in the hippocampal formation is an early phenomenon in Alzheimer's disease. Neuroscience 64:375-384.
12. Hodges-Savola C, Rogers SD, Ghilardi JR, Timm DR, Mantyh PW (1996) β-adrenergic receptors regulate astrogliosis and cell proliferation in the central nervous system in vivo. Glia 17:52-62.
13. Hsiao KK, Borchelt DR, Olson K, Johannsdottir R, Kitt C, Yunis W, Xu S, Eckman C, Younkin S, Price D, Iadecola C, Clark HB, Carlson G (1995) Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins. Neuron 15:1203-1218.
14. Iwamoto N, Kobayashi K, Kosaka K (1989) The formation of prostaglandins in the postmortem cerebral cortex of Alzheimer-type dementia patients. J Neurol 236:80-84.
15. 2-receptors in prefrontal cortex and hippocampus. J Neurochem 53:1772-1781. mcKametani F, Tanaka K, Ishii T, Ikeda S, Kennedy HE, Allsop D (1993) Secretory form of Alzheimer amyloid precursor protein 695 in human brain lacks β/A4 amyloid immunoreactivity. Biochem Biophys Res Commun 191:392-398.
16. 2-receptors in prefrontal cortex and hippocampus. J Neurochem 53:1772-1781. mcKametani F, Tanaka K, Ishii T, Ikeda S, Kennedy HE, Allsop D (1993) Secretory form of Alzheimer amyloid precursor protein 695 in human brain lacks β/A4 amyloid immunoreactivity. Biochem Biophys Res Commun 191:392-398.
17. Lee RKK, Wurtman RJ, Cox AJ, Nitsch RM (1995) Amyloid precursor protein processing is stimulated by metabotropic glutamate receptors. Proc Natl Acad Sci USA 92:8083-8087.
18. 2 stimulates overexpression of amyloid precursor protein in astrocyte cultures: inhibition by immunosuppressants. J Neurochem [Suppl] 69:S103B.
19. Lee RKK, Araki W, Wurtman RJ (1997b) Stimulation of amyloid precursor protein synthesis by adrenergic receptors coupled to cAMP formation. Proc Natl Acad Sci USA 94:5422-5426.
20. Marks AR (1996) Cellular functions of immunophilins. Physiol Rev 76:631-649.
21. McCarthy KD, de Vellis J (1980) Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 85:890-902.
22. McGeer P, McGeer EG (1995) The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Rev 21:195-218.
23. Nitsch RM, Slack BE, Wurtman RJ, Growdon JH (1992) Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. Science 258:304-307.
24. Paresce DM, Ghosh RN, Maxfield FR (1996) Microglial cells internalize aggregates of the Alzheimer's disease amyloid β-protein via a scavenger receptor. Neuron 17:553-565.
25. Sabatini DM, Erdjument-Bromage H, Lui M, Tempst P, Snyder SH (1994) RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs. Cell 78:35-43.
26. Salbaum JM, Weidemann A, Lemaire H-G, Masters CL, Beyreuther K (1988) The promoter of Alzheimer's disease amyloid A4 precursor gene. EMBO J 7:2807-2813.
27. 2+-dependent phosphatase calcineurin in gene transcription that is stimulated by cAMP through cAMP response elements. J Biol Chem 270:8860-8866.
28. Selkoe DJ, Podlisny MB, Joachim CL, Vickers EA, Lee G, Fritz LC, Oltersdorf T (1988) β-amyloid precursor protein of Alzheimer disease occurs as 110-to 135-kilodalton membrane associated proteins in neural and nonneuronal tissues. Proc Natl Acad Sci USA 85:7341-7345.
29. Shekarabi M, Bourbonniere M, Dagenais A, Nalbantoglu J (1997) Transcriptional regulation of amyloid precursor protein during dibutyryl cyclic AMP-induced differentiation of NG108-15 cells. J Neurochem 68:970-978.
30. Siman R, Card JP, Nelson RB, Davis LG (1989) Expression of β-amyloid precursor protein in reactive astrocytes following neuronal damage. J Neurosci 3:275-285.
31. Sisodia SS, Koo EH, Beyreuther K, Unterbeck A, Price D (1990) Evidence that β-amyloid protein in Alzheimer's disease is not derived by normal processing. Science 248:492-495.
32. Slack BE, Breu J, Petryniak MA, Srivastava K, Wurtman RJ (1995) Tyrosine phosphorylation-dependent stimulation of amyloid precursor protein secretion by the m3 muscarinic acetylcholine receptor. J Biol Chem 270:8337-8344.
33. Slunt HH, Thinakaran G, Koch C, Lo ACY, Tanzi RE, Sisodia SS (1994) Expression of a ubiquitous, cross-reactive homologue of the mouse β-amyloid precursor protein (APP). J Biol Chem 269:2637-2644.
34. Solá C, Garcia-Ladona FJ, Mengod G, Probst A, Frey P, Palacios JM (1993) Increased levels of the Kunitz protease inhibitor-containing βAPP mRNAs in rat brain following neurotoxic damage. Mol Brain Res 17:41-52.
35. Steiner JP, Connolly MA, Valentine HL, Hamilton GS, Dawson TM, Hester L, Snyder SH (1997) Neurotrophic actions of nonimmunosuppressive analogues of immunosuppressive drugs FK506, rapamycin and cyclosporin A. Nat Med 3:421-428.
36. 2) immunoreactivity is elevated in Alzheimer's disease brain. Neurobiol Dis 3:51-63.
37. Subbarao KV, Richardson JS, Ang LC (1990) Autopsy samples of Alzheimer's cortex show increased peroxidation in vitro. J Neurochem 55:342-345.
38. Tanaka S, Shiojiri S, Takahashi Y, Kitaguchi N, Ito H, Kameyama M, Kimura J, Nakamura S, Ueda K (1989) Tissue-specific expression of three types of β-protein precursor mRNA: enhancement of protease inhibitor-harboring types in Alzheimer's disease brains. Biochem Biophys Res Commun 165:1406-1414.
39. Ulus IH, Wurtman RJ (1997) Metabotropic glutamate receptor agonists increase release of soluble amyloid precursor protein derivatives from rat brain cortical and hippocampal slices. J Pharmacol Exp Ther 281:149-154.
40. Wallin A, Blennow K, Rosengren LE (1996) Glial fibrillary acidic protein in the cerebrospinal fluid of patients with dementia. Dementia 7:267-272.
41. Weidemann A, König G, Bunke D, Fischer P, Salbaum JM, Masters CL, Beyreuther K (1989) Identification, biogenesis and localization of precursors of Alzheimer's disease A4 amyloid protein. Cell 57:115-126.
42. Yoshikawa K, Aizawa T, Hayashi Y (1992) Degeneration in vitro of post-mitotic neurons overexpressing the Alzheimer amyloid protein precursor. Nature 359:64-67.